Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Terlipax Terlipressin Injection 0.1 mg
Terlipax Terlipressin Injection 0.1 mg is a crucial intervention in emergency settings, particularly for patients suffering from variceal bleeding due to liver cirrhosis. Terlipressin, the active ingredient, is a synthetic vasopressin analog that acts to reduce portal pressure and control bleeding in the gastrointestinal tract.
Uses of Terlipax Terlipressin Injection 0.1 mg
Bleeding Esophageal Varices: Used to control and manage acute bleeding from esophageal varices, which are common complications in patients with liver cirrhosis.
Hepatorenal Syndrome (HRS): Can be used in treating HRS, a condition often seen in patients with advanced liver disease, characterized by kidney dysfunction.
Shock Management: Employed in some cases of septic shock due to its vasoconstrictive properties.
Benefits of Terlipax Terlipressin Injection 0.1 mg
Effective Hemostasis: Quickly controls bleeding from esophageal varices, reducing the risk of severe blood loss.
Reduces Portal Hypertension: Helps in decreasing the pressure in the portal vein, which is often elevated in liver cirrhosis, thereby preventing further variceal bleeding.
Short-Term Treatment: Provides a rapid therapeutic response in emergency situations.
Improves Survival Rates: By effectively managing variceal bleeding, it improves patient outcomes and reduces mortality.
Versatile Use: Can be used in different clinical scenarios including HRS and septic shock management.
Mechanism of Action of Terlipax Terlipressin Injection 0.1 mg
Terlipressin, the active component in Terlipax Terlipressin Injection 0.1 mg, is a synthetic analogue of vasopressin, a naturally occurring hormone. It acts primarily through vasoconstriction, which is mediated by V1 receptors present on the smooth muscle cells of blood vessels.